Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louis Buscail

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2006
Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growthFabienne Vernejoul, Laurent Ghénassia, Anny Souque, et al.
World Journal of Gastroenterology|May 31, 2006
Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samplesHenrik Laurell, Michele Bouisson, Philippe Berthelemy, et al.
Cancers|February 15, 2022
Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous PolyposisGuillaume Le Cosquer, Etienne Buscail, Cyrielle Gilletta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 9, 2011
Oxalate nephropathy associated with chronic pancreatitisClaire Cartery, Stanislas Faguer, Alexandre Karras, et al.
Cancers|March 12, 2020
Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be ImplementedDominique Farge, Barbara Bournet, Thierry Conroy, et al.
Clinical and Translational Gastroenterology|March 25, 2016
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic AdenocarcinomaBarbara Bournet, Fabrice Muscari, Camille Buscail, et al.
Molecular Therapy. Methods & Clinical Development|April 17, 2023
Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancerOdile Barbey, Hubert Lulka, Naima Hanoun, et al.
Endoscopy International Open|June 13, 2022
Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapyLouis Buscail, Adrian Culetto, Fatima-Zhora Mokhrane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumorsAmani Asnacios, Frédéric Courbon, Philippe Rochaix, et al.
Journal of Hepatology|August 31, 2010
The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functionsNaïma Hanoun, Christophe Bureau, Thoria Diab, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 27, 2006
Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growthFabienne Vernejoul, Laurent Ghénassia, Anny Souque, et al.
World Journal of Gastroenterology|May 31, 2006
Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samplesHenrik Laurell, Michele Bouisson, Philippe Berthelemy, et al.
Cancers|February 15, 2022
Incidence and Risk Factors of Cancer in the Anal Transitional Zone and Ileal Pouch following Surgery for Ulcerative Colitis and Familial Adenomatous PolyposisGuillaume Le Cosquer, Etienne Buscail, Cyrielle Gilletta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 9, 2011
Oxalate nephropathy associated with chronic pancreatitisClaire Cartery, Stanislas Faguer, Alexandre Karras, et al.
Cancers|March 12, 2020
Primary Thromboprophylaxis in Pancreatic Cancer Patients: Why Clinical Practice Guidelines Should Be ImplementedDominique Farge, Barbara Bournet, Thierry Conroy, et al.
Clinical and Translational Gastroenterology|March 25, 2016
KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic AdenocarcinomaBarbara Bournet, Fabrice Muscari, Camille Buscail, et al.
Molecular Therapy. Methods & Clinical Development|April 17, 2023
Preclinical development of non-viral gene therapy for patients with advanced pancreatic cancerOdile Barbey, Hubert Lulka, Naima Hanoun, et al.
Endoscopy International Open|June 13, 2022
Endoscopic ultrasound as a reliable tool for assessment of pancreatic adenocarcinoma treatment: Example of in situ gene therapyLouis Buscail, Adrian Culetto, Fatima-Zhora Mokhrane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2008
Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumorsAmani Asnacios, Frédéric Courbon, Philippe Rochaix, et al.
Journal of Hepatology|August 31, 2010
The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functionsNaïma Hanoun, Christophe Bureau, Thoria Diab, et al.
Pageof 12